Therapeutic Surgery for Nonepithelioid Malignant Pleural Mesothelioma: Is it Really Worthwhile?

Annals of Thoracic Surgery

Volumn 89, Issue 3, 2010, Pages 907-911

  Balduyck, Bram ^a   Trousse, Delphine ^a   Nakas, Apostolos ^a   Martin Ucar, Antonio E ^a   Edwards, John ^a   Waller, David A ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE; MITOMYCIN; NAVELBINE; PEMETREXED; VINBLASTINE;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BIPHASIC TUMOR; CANCER SURVIVAL; CELL TYPE; CONTROLLED STUDY; DECORTICATION; EPITHELIOID TUMOR; FEMALE; HUMAN; HUMAN TISSUE; LEUKOCYTOSIS; LUNG RESECTION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PLEURECTOMY; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; SARCOMATOID TUMOR; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; THORAX SURGERY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL NEOPLASMS; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 76749168047     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.12.041     Document Type: Article

References (18)

1. Pelucchi C., Malvezzi M., La Vecchia C., Levi F., Decarti A., and Negri E. The mesothelioma epidemic in Western Europe: an update. Br J Cancer 90 (2004) 1022-1024
2. Van Gelder T., Damhuis R.A., and Hoogstede H.C. Prognostic factors and survival in malignant pleural mesothelioma. Eur Respir J 7 (1994) 1035-1038
3. Flores R.M., Pass H.I., Seshan V.E., et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135 (2008) 620-626
4. Borasio P., Berruti A., Billé A., et al. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Cardiothorac Surg 33 (2008) 307-313
5. Weder W., Stahel R.A., Bernhard J., et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 18 (2007) 1196-1202
6. Nakas A., Martin-Ucar A.E., Edwards J.G., and Waller D.A. The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 33 (2008) 83-88
7. Edwards J.G., Martin-Ucar A.E., Stewart D.J., and Waller D.A. Right extrapleural pneumonectomy for malignant mesothelioma via median sternotomy or thoracotomy?. Short- and long-term results. Eur J Cardiothorac Surg 31 (2007) 759-764
8. Martin-Ucar A.E., Nakas A., Edwards J.G., and Waller D.A. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma. Eur J Cardiothorac Surg 31 (2007) 765-771
9. Rusch V.W., and The International Mesothelioma Interest Group. A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 108 (1995) 1122-1128
10. Antman K., Shemin R., Ryan L., et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol 6 (1988) 147-153
11. Curran D., Sahmoud T., Therasse P., van Meerbeeck J., Postmus P.E., and Giaccone G. Prognostic factors in patients with pleural mesothelioma: the European Organisation for Research and Treatment of Cancer experience. J Clin Oncol 16 (1998) 145-152
12. Schildge J., Kaiser D., Henss H., Fiebig H., and Ortlieb H. Prognostic factors in diffuse malignant mesothelioma of the pleura. Pneumologie 43 (1989) 660-664
13. Johansson L., and Lindén C.J. Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas. Chest 109 (1996) 109-114
14. Merritt N., Blewett C.J., Miller J.D., Bennett W.F., Young J.E., and Urschel J.D. Survival after conservative management of pleural mesothelioma. J Surg Oncol 78 (2001) 171-174
15. Sugarbaker D.J. Editorial comment made on Martin-Ucar AE, Nakas A, Edwards JG, Waller DA. Case control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma. Eur J Cardiothorac Surg 31 (2007) 770-771
16. Van Gelder T., Hoogsteden H.C., Vandenbroucke J.P., van der Kwast T.H., and Planteydt H.T. The influence of the diagnostic technique on the histopathological diagnosis of malignant mesotheliomas. Virchows Arch A Pathol Anat Histopathol 418 (1991) 315-317
17. Edwards J.G., Swinson D.E.B., Jones J.L., Waller D.A., and O'Byrne K.J. EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma. Lung Cancer 54 (2006) 399-407
18. Dazzi H., Hasleton P.S., Thatcher N., Wilkes S., Swindel R., and Chatterjee A.K. Malignant pleural mesothelioma and epidermal growth factor receptor (EGFR). Relationship of EGFR with histology and survival using fixed paraffin embedded tissue and the F4 monoclonal antibody. Br J Cancer 61 (1990) 924-926